50
Views
66
CrossRef citations to date
0
Altmetric
Original Article

Eradication of Helicobacter pylori Affects Symptoms in Non-Ulcer Dyspepsia

, , , &
Pages 535-540 | Received 18 Nov 1996, Accepted 12 Feb 1997, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Harry Hua-Xiang Xia, Benjamin Chun Yu Wong, Nicholas J Talley & Shiu Kum Lam. (2001) Helicobacter pylori infection - current treatment practice. Expert Opinion on Pharmacotherapy 2:2, pages 253-266.
Read now
Johanna I. Westbrook, Jean H. McIntosh, Nicholas J. Talley. (2000) The Impact of Dyspepsia Definition on Prevalence Estimates: Considerations for Future Researchers. Scandinavian Journal of Gastroenterology 35:3, pages 227-233.
Read now
G. Manes, S. Mosca, M. Laccetti, M. Lioniello, A. Balzano. (1999) Helicobacter pylori Infection, Pattern of Gastritis, and Symptoms in Erosive and Nonerosive Gastroesophageal Reflux Disease. Scandinavian Journal of Gastroenterology 34:7, pages 658-662.
Read now
Wink A. De Boer. (1997) Helicobacter pylori and Non-Ulcer Dyspepsia. Scandinavian Journal of Gastroenterology 32:11, pages 1183-1184.
Read now

Articles from other publishers (62)

Kentaro Sugano. (2011) Should We Still Subcategorize -Associated Dyspepsia as Functional Disease?. Journal of Neurogastroenterology and Motility 17:4, pages 366-371.
Crossref
Paul Moayyedi, Shelly Soo, Jonathan J Deeks, Brendan Delaney, Adam Harris, Michael Innes, R Oakes, Sue Wilson, A Roalfe, Cathy Bennett & David Forman. (2011) Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database of Systematic Reviews.
Crossref
Kok-Ann Gwee, Leyan Teng, Reuben-KM Wong, Khek-Yu Ho, Dede-Selamat Sutedja & Khay-Guan Yeoh. (2009) The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology 21:4, pages 417-424.
Crossref
Xi Jin & You-ming Li. (2007) Systematic Review and Meta-analysis from Chinese Literature: the Association Between Helicobacter pylori Eradication and Improvement of Functional Dyspepsia. Helicobacter 12:5, pages 541-546.
Crossref
William D. Chey & Benjamin C.Y. Wong. (2007) American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection. The American Journal of Gastroenterology 102:8, pages 1808-1825.
Crossref
André JPM Smout. (2006) Advantages and disadvantages of lumping together gastroesophageal reflux disease and dyspepsia. Current Opinion in Gastroenterology 22:4, pages 412-416.
Crossref
Paul Moayyedi, Shelly Soo, Jonathan J Deeks, Brendan Delaney, Adam Harris, Michael Innes, R Oakes, Sue Wilson, A Roalfe, Cathy Bennett & David Forman. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
HUCK JOO TAN, ABDUL MANAF RIZAL, MOHAMED-YUSOFF ROSMADI & KHEAN-LEE GOH. (2006) Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia . Journal of Gastroenterology and Hepatology 21:1, pages 110-115.
Crossref
Francesco Di Mario, Nicoletta Stefani, Nadia Dal Bò, Massimo Rugge, Alberto Pilotto, Giulia Martina Cavestro, Lucas Giovanni Cavallaro, Angelo Franzé & Gioacchino Leandro. (2005) Natural Course of Functional Dyspepsia After Helicobacter pyloriEradication: A Seven-Year Survey. Digestive Diseases and Sciences 50:12, pages 2286-2295.
Crossref
E. A. Ott, L. E. Mazzoleni, M. I. Edelweiss, G. B. Sander, A. C. Wortmann, A. L. Theil, G. Somm, A. Cartell, L. F. Rivero, D. M. Uchoa, C. F. Francesconi & J. C. Prolla. (2005) Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial. Alimentary Pharmacology and Therapeutics 21:10, pages 1231-1239.
Crossref
P Moayyedi, S Soo, J Deeks, B Delaney, A Harris, M Innes, R Oakes, S Wilson, A Roalfe, C Bennett & D Forman. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
T Leivo, A Salomaa, T.U Kosunen, R Tuominen, M Färkkilä, M Linna & H Sintonen. (2004) Cost–benefit analysis of Helicobacter pylori screening. Health Policy 70:1, pages 85-96.
Crossref
Filippo Cremonini, Silvia Delgado-Aros & Nicholas J. Talley. (2004) Functional dyspepsia: drugs for new (and old) therapeutic targets. Best Practice & Research Clinical Gastroenterology 18:4, pages 717-733.
Crossref
Villy Meineche-Schmidt. (2004) Empiric Treatment with High and Standard Dose of Omeprazole in General Practice: Two-Week Randomized Placebo-Controlled Trial and 12-Month Follow-Up of Health-care Consumption. The American Journal of Gastroenterology 99:6, pages 1050-1058.
Crossref
David A Peura, Thomas O.G Kovacs, David C Metz, Nancy Siepman, Betsy L Pilmer & Nicholas J Talley. (2004) Lansoprazole in the treatment of functional dyspepsia: Two Double-Blind, Randomized, Placebo-Controlled trials. The American Journal of Medicine 116:11, pages 740-748.
Crossref
Limas Kupcinskas, Laimas Jonaitis & Gediminas Kiudelis. (2004) A 1 year follow-up study of the consequences of Helicobacter pylori eradication in duodenal ulcer patients. European Journal of Gastroenterology & Hepatology 16:4, pages 369-374.
Crossref
Pedro González Carro, M. Luisa Legaz Huidobro, Francisco Pérez Roldán, José Miguel Esteban López Jamar, Juan Carlos Valenzuela Gámez, Ana Ponte Tellechea, Francisco Ruiz Carrillo, Carmen Pedraza Martín, Francisco Díaz de Rojas & José M. Sáez Bravo. (2004) Eficacia de la erradicación de Helicobacter pylori en la dispepsia no ulcerosa. Medicina Clínica 122:3, pages 87-91.
Crossref
Sander Zanten, Richard N. Fedorak, Jean Lambert, Lawrence Cohen & Anita Vanjaka. (2003) Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia. The American Journal of Gastroenterology 98:9, pages 1963-1969.
Crossref
P. Malfertheiner, J. MÖssner, W. Fischbach, P. Layer, A. Leodolter, M. Stolte, K. Demleitner & W. Fuchs. (2003) Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia . Alimentary Pharmacology & Therapeutics 18:6, pages 615-625.
Crossref
M. Saruc, N. Ozden, N. Turkel, S. Ayhan, M.A. Demir, I. Tuzcuoglu, U.S. Akarca & H. Yuceyar. (2003) Functional dyspepsia: relationship between clinical subgroups and Helicobacter pylori status in Western Turkey. Brazilian Journal of Medical and Biological Research 36:6, pages 747-751.
Crossref
H. H.-X. Xia, N. J. Talley, A. L. Blum, C. A. O'Morain, M. Stolte, E. Bolling-Sternevald & H. M. Mitchell. (2003) Clinical and pathological implications of IgG antibody responses to Helicobacter pylori and its virulence factors in non-ulcer dyspepsia . Alimentary Pharmacology & Therapeutics 17:7, pages 935-943.
Crossref
D. McNamara, M. Buckley, J. Gilvarry & C. O'Morain. (2002) Does Helicobacter pylori Eradication Affect Symptoms in Nonulcer Dyspepsia: A 5‐Year Follow‐Up Study . Helicobacter 7:5, pages 317-321.
Crossref
G. BODE, H. BRENNER, G. ADLER & D. ROTHENBACHER. (2002) Dyspeptic symptoms in middle‐aged to old adults: the role of Helicobacter pylori infection, and various demographic and lifestyle factors . Journal of Internal Medicine 252:1, pages 41-47.
Crossref
N. J. Talley & C. Quan. (2002) Helicobacter pylori and nonulcer dyspepsia . Alimentary Pharmacology & Therapeutics 16, pages 58-65.
Crossref
Ahmed Madisch, Jürgen Hotz, Gabriele Grabowski, Angelika Guth, Peter Malfertheiner, Klaus Plein & Berthold Schneider. (2002) Efficacy of Helicobacter pylori eradication in uninvestigated chronic dyspeptic staff members of a large factory: a prospective, long-term, follow-up, workplace outcome study. European Journal of Gastroenterology & Hepatology 14:1, pages 61-69.
Crossref
Benjamin D. Gold. (2001) Helicobacter pylori infection in children. Current Problems in Pediatrics 31:8, pages 247-266.
Crossref
F Froehlich, J J Gonvers, V Wietlisbach, B Burnand, P Hildebrand, C Schneider, E Saraga, C Beglinger & J P Vader. (2001) Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. American Journal of Gastroenterology 96:8, pages 2329-2336.
Crossref
K E L McColl. (2001) Protagonist: Should we eradicate Helicobacter pylori in non-ulcer dyspepsia? . Gut 48:6, pages 759-761.
Crossref
D Pantoflickova & A L Blum. (2001) Antagonist: Should we eradicate Helicobacter pylori in non-ulcer dyspepsia? . Gut 48:6, pages 758-759.
Crossref
Pippa E. S. Bowie, Rosamond A. Cox, Andrew R. Davidson & Andrew Steel. (2001) Young dyspeptic patients: with a test-and-treat policy, are the benefits of decreased symptom severity and oesophago-gastro-duodenoscopy workload sustained?. European Journal of Gastroenterology & Hepatology 13:5, pages 541-545.
Crossref
Benjamin D. Gold. (2001) New approaches to helicobacter pylori infection in children. Current Gastroenterology Reports 3:3, pages 235-247.
Crossref
V. Stanghellini. (2008) Pain versus discomfort—is differentiation clinically useful?. Alimentary Pharmacology & Therapeutics 15:2, pages 145-149.
Crossref
P.‐I. Hsu, K.‐H. Lai, H.‐H. Tseng, G.‐H. Lo, C.‐C. Lo, C.‐K. Lin, J.‐S. Cheng, H.‐H. Chan, M.‐K. Ku, N.‐J. Peng, E.‐J. Chien, W. Chen & P.‐N. Hsu. (2008) Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer‐like functional dyspepsia . Alimentary Pharmacology & Therapeutics 15:2, pages 195-201.
Crossref
Douglas B Nelson, Maureen Murdoch, Irfan K Sandozi, Agustin P Dalmasso, Jean E Crabtree & Samuel B Ho. (2000) Dyspepsia Is Associated With Caga-Positive Helicobacter Pylori. American Journal of Gastroenterology 95:12, pages 3412-3417.
Crossref
K.E.L. McColl. (2000) Helicobacter pylori and dyspepsia. Pro and against. Digestive and Liver Disease 32, pages 199-201.
Crossref
Deirdre A. Mc Namara, Martin Buckley & Colm A. O'Morain. (2000) Nonulcer Dyspepsia. Gastroenterology Clinics of North America 29:4, pages 807-818.
Crossref
Joshua J. Ofman. (2000) What have we learned from recent dyspepsia trials?. Current Gastroenterology Reports 2:6, pages 471-477.
Crossref
V. Stanghellini, C. Tosetti, G. Barbara, R. De Giorgio, B. Salvioli & R. Corinaldesi. (2000) The continuing dilemma of dyspepsia. Alimentary Pharmacology & Therapeutics 14, pages 23-30.
Crossref
E. Hentschel. (2000) Therapie der Helicobacter pylori-Infektion*. Acta Medica Austriaca 27:4, pages 104-108.
Crossref
Hession & Malagelada. (2001) Review article: the initial management of uninvestigated dyspepsia in younger patients—the value of symptom‐guided strategies should be reconsidered. Alimentary Pharmacology & Therapeutics 14:4, pages 379-388.
Crossref
Hiroto Miwa & Nobuhiro Sato. (2002) Functional dyspepsia and Helicobacter pylori infection: A recent consensus up to 1999 . Journal of Gastroenterology and Hepatology 15:s1, pages 60-65.
Crossref
Miwa, Hirai, Nagahara, Murai, Nishira, Kikuchi, Takei, Watanabe & Sato. (2001) Cure of Helicobacter pylori infection does not improve symptoms in non‐ulcer dyspepsia patients—a double‐blind placebo‐controlled study . Alimentary Pharmacology & Therapeutics 14:3, pages 317-324.
Crossref
. (2000) Absence of Benefit of Eradicating Helicobacter pylori in Patients with Nonulcer Dyspepsia . New England Journal of Medicine 342:8, pages 589-590.
Crossref
T. Murai, H. Miwa, R. Ohkura, R. Iwazaki, A. Nagahara, K. Sato, T. Yamada, K. Ota, H. Tanaka, M. Kawabe, T. Minowa, Y. Takei, A. Miyazaki & N. Sato. (2000) The incidence of reflux oesophagitis after cure of Helicobacter pylori in a Japanese population. Alimentary Pharmacology & Therapeutics 14, pages 161-165.
Crossref
Kenneth McColl. (2008) Should Non‐Invasive Helicobacter pylori Testing Replace Endoscopy in Investigation of Dyspepsia? . Helicobacter 5:S1, pages 11-15.
Crossref
S. J. O. Veldhuyzen van Zanten. 2000. Helicobacter pylori. Helicobacter pylori 435 441 .
A. G. Klauser & S. Müller-Lissner. 2000. Klinische Gastroenterologie und Stoffwechsel. Klinische Gastroenterologie und Stoffwechsel 159 169 .
Miyaji, Azuma, Ito, Abe, Ono, Suto, Ito, Yamazaki, Kohli & Kuriyama. (2001) The effect of Helicobacter pylori eradication therapy on gastric antral myoelectrical activity and gastric emptying in patients with non‐ulcer dyspepsia . Alimentary Pharmacology & Therapeutics 13:11, pages 1473-1480.
Crossref
Woodward, Morrison & Mccoll. (2001) The prevalence of dyspepsia and use of antisecretory medication in North Glasgow: role of Helicobacter pylori vs. lifestyle factors . Alimentary Pharmacology & Therapeutics 13:11, pages 1505-1509.
Crossref
Miyaji, Azuma, Ito, Abe, Ono, Suto, Ito, Yamazaki, Kohli & Kuriyama. (2001) The effect of Helicobacter pylori eradication therapy on gastric antral myoelectrical activity and gastric emptying in patients with non‐ulcer dyspepsia . Alimentary Pharmacology & Therapeutics 13:10, pages 1303-1309.
Crossref
Patrick R Pfau & David C Metz. (1999) Helicobacter Pylori and Nonulcer Dyspepsia: More Confusion?. American Journal of Gastroenterology 94:9, pages 2563-2565.
Crossref
Talley, Axon, Bytzer, Holtmann, Lam & S. Velohuyzen Van Zanten. (2001) Management of uninvestigated and functional dyspepsia: a working party report for the World Congresses of Gastroenterology 1998. Alimentary Pharmacology & Therapeutics 13:9, pages 1135-1148.
Crossref
Gopal Krishan Dhali, Pramod Kumar Garg & Mahesh Prakash Sharma. (2008) Role of anti‐ Helicobacter pylori treatment in H. pylori ‐positive and cytoprotective drugs in H. pylori ‐negative, non‐ulcer dyspepsia: Results of a randomized, double‐blind, controlled trial in Asian Indians . Journal of Gastroenterology and Hepatology 14:6, pages 523-528.
Crossref
J. Kalantar, G. D. Eslick & N. J. Talley. 1999. Gastroduodenal Disease and Helicobacter pylori. Gastroduodenal Disease and Helicobacter pylori 31 45 .
Mark Pimentel & Henry C. Lin. 1999. Gastrointestinal Motility. Gastrointestinal Motility 285 294 .
Lawrence S. Friedman. (1998) Helicobacter pylori and Nonulcer Dyspepsia . New England Journal of Medicine 339:26, pages 1928-1930.
Crossref
Kenneth McColl, Lilian Murray, Emad El-Omar, Anthea Dickson, Adil El-Nujumi, Angela Wirz, Andrew Kelman, Christine Penny, Robin Knill-Jones & Thomas Hilditch. (1998) Symptomatic Benefit from Eradicating Helicobacter pylori Infection in Patients with Nonulcer Dyspepsia . New England Journal of Medicine 339:26, pages 1869-1874.
Crossref
Drahoslava Pantoflickova, AndréL. Blum & Hans R. Koelz. (1998) 7 Helicobacter pylori and functional dyspepsia: a real causal link?. Baillière's Clinical Gastroenterology 12:3, pages 503-532.
Crossref
Gerald Holtmann, Vincenzo Stanghellini & Nicholas J. Talley. (1998) 1 Nomenclature of dyspepsia, dyspepsia subgroups and functional dyspepsia: Clarifying the concepts. Baillière's Clinical Gastroenterology 12:3, pages 417-433.
Crossref
CHING‐LIANG LU, FULL‐YOUNG CHANG, TSENG‐SHING CHEN, CHIH‐YEN CHEN, KANG LIH JIUN & SHOU‐DONG LEE. (2008) Helicobacter pylori colonization does not influence the symptomatic response to prokinetic agents in patients with functional dyspepsia. Journal of Gastroenterology and Hepatology 13:5, pages 500-504.
Crossref
SK LAM & NJ TALLEY. (1998) Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 13:1, pages 1-12.
Crossref
John Lee & Colm O'Morain. (1997) Who Should Be Treated for Helicobacter pylori Infection? A Review of Consensus Conferences and Guidelines. Gastroenterology 113:6, pages S99-S106.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.